John Wharton to Treatment Outcome
This is a "connection" page, showing publications John Wharton has written about Treatment Outcome.
Connection Strength
0.115
-
Cardiac Computed Tomography for Atrial Fibrillation Patients Undergoing Ablation: Implications for the Prediction of Early Recurrence. J Thorac Imaging. 2020 May; 35(3):186-192.
Score: 0.019
-
Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries. J Am Coll Cardiol. 2000 Feb; 35(2):428-41.
Score: 0.019
-
Effect of increased parasympathetic and sympathetic tone on internal atrial defibrillation thresholds in humans. Pacing Clin Electrophysiol. 1999 Jan; 22(1 Pt 2):238-42.
Score: 0.017
-
Radiofrequency catheter ablation of atrial tachycardia and atrial flutter. Coron Artery Dis. 1996 Jan; 7(1):12-9.
Score: 0.014
-
Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion. J Cardiovasc Transl Res. 2013 Aug; 6(4):528-35.
Score: 0.012
-
Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72.
Score: 0.010
-
The effect of dofetilide on ventricular defibrillation thresholds. Pacing Clin Electrophysiol. 2009 Jan; 32(1):24-8.
Score: 0.009
-
Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
Score: 0.009
-
Atrial fibrillation originating from persistent left superior vena cava. Circulation. 2004 Feb 24; 109(7):828-32.
Score: 0.006